New Market Research Report on U.S. Clinical Laboratory Market

New Market Research Report on U.S. Clinical Laboratory Market

New Market Research Report on U.S. Clinical Laboratory Market

Laboratory Economics has just released The U.S. Clinical Laboratory  Industry Forecast & Trends 2023-2025. With this special report, you can 
tap into 100+ pages of proprietary market research that reveals critical  
data and information about key business trends affecting the U.S.
laboratory testing market.

The report reveals that the U.S. laboratory testing market represented
an estimated $125 billion of revenue in 2023 with a long-term annual
growth rate of 3-4%. Growth is currently being driven almost entirely by
increased PCR-based microbiology testing.

The U.S. laboratory testing market faces unprecedented challenges,
including the post-pandemic employee wage inflation, greater utilization
management and claims denials by private payers and persistent
reimbursement pressure. Despite these challenges, the U.S. lab industry
has shown persistent growth.

“The adoption of new higher-priced PCR-based test panels for respiratory
viruses, UTIs and STDs is helping to offset price and volume pressure on
routine clinical lab tests,” according to Jondavid Klipp, President of
Laboratory Economics.

The report includes:

  • More than 100 charts and graphs
  • U.S. lab market size and growth rates for 2012-2025
  • Detailed estimates for market subsets like hospital-based labs,
    independent labs, and physician-office-based labs
  • In-depth analysis of the PCR-based testing market size, growth rate,
    and highest-volume laboratories
  • Top 50 hospital outreach labs by Medicare CLFS and PFS payments
  • Detailed reimbursement rate information from Medicare CLFS, Aetna,
    Cigna, UnitedHealthcare, etc.
  • Comprehensive lab M&A valuation metrics by revenue and EBITDA
  • Results from Laboratory Economics Clinical Lab Trends Surveys from
    2014 through 2023
  • The biggest challenges and opportunities for labs

Laboratory companies highlighted include:

  • ACL Laboratories
  • ARUP Laboratories
  • Exact Sciences
  • Fulgent Genetics
  • Labcorp
  • Mayo Clinic Laboratories
  • Myriad Genetics
  • NeoGenomics
  • Northwell Health Labs
  • OPKO/BioReference Labs
  • PathAI/Poplar Healthcare
  • PathGroup
  • Quest Diagnostics
  • Sonic Healthcare

The U.S. Clinical Laboratory Industry: Forecast & Trends 2023-2025 is
published by Laboratory Economics (, an
independent market research firm focused exclusively on the business of
pathology and laboratory medicine.

Special New Year’s Report: Lab Execs Share Outlook for 2019

Special New Year’s Report: Lab Execs Share Outlook for 2019

Special New Year’s Report: Lab Execs Share Outlook for 2019

For an inside look at what may be in store for the clinical lab and pathology business this year, Laboratory Economics interviewed the top executives at a diverse group of 10 lab companies.

Not surprisingly, our interviews revealed that commercial insurers are using Medicare’s repricing of the CLFS as a pretext to cut their own rates. What is surprising (and alarming) is that some commercial insurers have demanded the full three-year phased-in ~30% CLFS reduction applied to their rates upfront immediately.

Labs are hoping to offset the pricing pressure by gaining economies of scale through geographic and test menu expansion. On the brighter side, the extreme pricing pressure that terrorized technical services for anatomic pathology seems to be over. Furthermore, molecular diagnostics and prescription drug monitoring continue to be high-growth markets.

  • Pricing pressure from both Medicare and commercial insurers
  • High volume growth in molecular diagnostics and prescription drug monitoring
  • Anatomic pathology reimbursement rates have stabilized
  • Hospital outreach labs benefiting from health system acquisitions of physician practices
  • Nursing home labs are restructuring and consolidating

Companies profiled in the January 2019 issue of Laboratory Economics include Sonic Healthcare USA, NeoGenomics, Health Network Laboratories, CellNetix, TriCore Reference Labs, Enzo Clinical Labs, Clinical Laboratory Services, CellMax Life, Psychemedics and Wisconsin Diagnostic Labs.